betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam

RxCUI: 1716094
RxNorm name: betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam
Display name: betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam
Full name: betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ENSTILAR	CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE	LEO Pharma Inc.	d1193df2-d53f-4342-bd9d-d9cba7c89709	2021-10-18	Warnings, Adverse reactions	Exact identifier rxcui: 1716094

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
d1193df2-d53f-4342-bd9d-d9cba7c89709	betamethasone dipropionate 0.643 MG/ML / calcipotriene 0.05 MG/ML Topical Foam	SCD	15	These highlights do not include all the information needed to use ENSTILAR Foam safely and effectively. See full prescribing information for ENSTILAR Foam. ENSTILAR ® (calcipotriene and betamethasone dipropionate) foam, for topical use Initial U.S. Approval: 2006	20211018
d1193df2-d53f-4342-bd9d-d9cba7c89709	calcipotriene 0.005 % / betamethasone propionate 0.064 % Topical Foam	SY	15	These highlights do not include all the information needed to use ENSTILAR Foam safely and effectively. See full prescribing information for ENSTILAR Foam. ENSTILAR ® (calcipotriene and betamethasone dipropionate) foam, for topical use Initial U.S. Approval: 2006	20211018
d1193df2-d53f-4342-bd9d-d9cba7c89709	calcipotriene 0.005 % / betamethasone propionate 0.064 % Topical Foam	PSN	15	These highlights do not include all the information needed to use ENSTILAR Foam safely and effectively. See full prescribing information for ENSTILAR Foam. ENSTILAR ® (calcipotriene and betamethasone dipropionate) foam, for topical use Initial U.S. Approval: 2006	20211018